In a major breakthrough for vascular medicine, Dr. Smile Medical Group has announced the launch of VaricoSeek 1.0, the first AI-powered system dedicated to the diagnosis and management of varicose veins. Developed in collaboration with Tencent’s AI research team, this cutting-edge technology is set to transform clinical workflows and improve patient outcomes worldwide.

A New Standard in AI-Assisted Venous Care

VaricoSeek integrates advanced hemodynamic analysis with a vast database of global venous disease expertise, offering clinicians a real-time, AI-driven assistant trained by international vascular surgery specialists. The system provides accurate, evidence-based insights to support medical professionals in diagnosis and treatment planning.

According to Dr. Smile Medical Group, the introduction of VaricoSeek marks a significant step forward in the application of AI to vascular health. “This technology is designed to enhance clinical decision-making, ensuring that both practitioners and patients benefit from faster, more precise medical insights,” a spokesperson for the company stated.

Key Features and Clinical Benefits

• Instant AI-Powered Decision Support – The system delivers medical insights within 10 seconds, assisting in rapid diagnosis and treatment planning.
• 24/7 Clinical Accessibility – VaricoSeek operates around the clock, providing medical professionals with continuous support beyond traditional consultation hours.
• Multilingual Capabilities – With support for over 10 languages, the platform ensures seamless communication for diverse patient populations.
• Integration with Global CHIVA Protocols – Aligns with internationally recognized venous treatment standards to provide evidence-based recommendations.
• AI Hallucination Filtering – A specialized algorithm eliminates misinformation, ensuring the accuracy of AI-generated responses.
• Privacy and Security Compliance – The system uses encrypted communication to protect patient data and meets international data protection regulations.

As part of its global expansion, Dr. Smile Medical Group is set to launch VaricoSeek Pro this April, alongside the opening of its new U.S. headquarters in Manhattan. The enhanced version will connect patients worldwide with top vascular specialists, further advancing AI-driven precision medicine.

VaricoSeek is expected to redefine the role of AI in venous health, bridging the gap between cutting-edge research and clinical practice while setting new standards in vascular disease management.